Two new studies on the Efficacy, Tolerability and Safety of Kortos® HC cream and Kortos® HC Suppository have been carried out, found to be highly efficacous and well tolerated with no clinically relevant systemic or local side/adverse effects More
HEALTHPOINT, Ltd., a U.S. market leader in surgical, tissue management and dermatology products, has announced that the company has received a Notice of Allowance from the European Patent Office for its Trizenol antiseptic technology. More
HEALTHPOINT, Ltd., a U.S. market leader in infection prevention, tissue management and dermatology products, has announced that the company has received a Notice of Allowance from the European Patent Office for its Trizenol antiseptic technology. More